Taspase 1 Activators
Taspase 1 Activators are a carefully selected range of chemical compounds that indirectly enhance the function of Taspase 1 through distinct biochemical pathways. Forskolin and Dibutyryl-cAMP, through their elevation of cAMP levels, indirectly augment Taspase 1 by activating PKA, which is known to phosphorylate a variety of proteins, shifting the cellular environment to favor processes that could include Taspase 1's cleavage activity. Similarly, PMA acts as a PKC activator, modulating phosphorylation patterns within the cell, which may indirectly lead to the enhanced activation of Taspase 1 by promoting its interaction with target substrates. Ionomycin and Thapsigargin,by modulating intracellular calcium levels, could trigger downstream proteolytic processes that facilitate Taspase 1's functional role. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases, may indirectly potentiate Taspase 1 activity by maintaining a phosphorylation state that is conducive to its activation or stability.
Additionally, Epigallocatechin gallate (EGCG) and Staurosporine, through their actions as kinase inhibitors, could lead to a cellular state that inadvertently enhances Taspase 1 activity by shifting the equilibrium away from competing phosphorylation events. Anisomycin's role in activating JNK signaling could elevate factors that enhance Taspase 1's proteolytic functions, while Sphingosine 1-phosphate might modulate apoptotic and autophagic pathways, indirectly influencing Taspase 1's regulatory mechanisms. LY294002, by altering the PI3K/AKT pathway, could also play a role in the indirect enhancement of Taspase 1 by affecting the phosphorylation dynamics of its interacting proteins. Collectively, these Taspase 1 Activators, despite their varied primary targets, converge on a biochemical theme: the subtle manipulation of phosphorylation and calcium-dependent signaling pathways that, in turn, could bolster the activity of Taspase 1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate proteins involved in the regulation of protein trafficking and cleavage processes that may enhance Taspase 1's proteolytic activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that modulates intracellular signaling pathways. Activation of PKC can lead to phosphorylation events that could facilitate the trafficking or activation of Taspase 1 to its substrates. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. The rise in calcium concentration could activate calcium-dependent proteases that may assist in the processing and activation of Taspase 1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which leads to increased phosphorylation levels within the cell. This could indirectly enhance Taspase 1 activity by altering the phosphorylation state of proteins that regulate Taspase 1's function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits protein phosphatases, which could result in a phosphorylation pattern that favors Taspase 1 activation or its access to substrates. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases. By inhibiting competitive pathways, EGCG may indirectly enhance signaling pathways that lead to the functional activation of Taspase 1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator and also inhibits protein synthesis. Activation of JNK signaling may upregulate factors that promote Taspase 1's proteolytic cleavage activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate engages in signaling that regulates cellular processes such as apoptosis and autophagy. Modulation of these processes could indirectly enhance the activity of Taspase 1 by affecting its regulatory proteins. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA and can mimic the effects of increased cAMP in cells. This can enhance the phosphorylation of proteins that may interact with or regulate Taspase 1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that modifies AKT signaling. By altering the PI3K/AKT pathway, it may affect the phosphorylation state of proteins that interact with or modify Taspase 1, potentially enhancing its activity. | ||||||